Morgan Stanley maintains Celsius stock with $42 target

Published 18/03/2025, 13:26
Morgan Stanley maintains Celsius stock with $42 target

On Tuesday, Morgan Stanley (NYSE:MS) reiterated an Equalweight rating on Celsius Holdings (NASDAQ:CELH), with a consistent price target of $42.00. The stock, currently trading at $29.93, has shown significant volatility with a 13.6% gain year-to-date despite falling 66.6% over the past year. According to InvestingPro data, analyst targets range from $26 to $62, reflecting mixed sentiment in the market. The assessment followed an analysis of recent sales data, which showed a slight improvement for the Celsius brand in the last two weeks (L2W) ending March 8, 2025, within NielsenIQ xAOC+C channels. Sales decline slowed to -1.4% compared to -7.6% in the prior two weeks, and market share, excluding powders, rose by +10 basis points sequentially. Total (EPA:TTEF) distribution points (TDP) for Celsius experienced low double-digit growth, maintaining the same pace as before, while the decrease in sales velocity showed signs of moderation. The company maintains strong financial health with a current ratio of 3.62 and more cash than debt on its balance sheet, as revealed by InvestingPro analysis.

Morgan Stanley’s analyst noted the volatility of weekly data, which has been influenced by weather-related events such as storms leading to fluctuations in stock-up and de-load activities. Therefore, the firm places more emphasis on four-week trends, where Celsius’s sales were down by mid-single digits for both the latest and prior four-week periods.

In contrast, sales growth for Alani Nu, another brand in the energy drink market, has shown a significant increase, with year-over-year sales surging by more than 100%. Alani Nu’s market share also grew by +20 basis points sequentially, reaching approximately 5.5%. The combined market share of Celsius and Alani Nu increased by +20 basis points in the last two weeks and by +80 basis points sequentially for the last four weeks.

Despite these market share gains, the analyst expressed caution regarding Celsius’s stock, pointing to the ongoing weak retail sales for the Celsius brand and potential consumer overlap between Celsius and Alani Nu. The commentary suggested that the strategic moves being made may be from a defensive position rather than one of market strength. The firm’s stance on Celsius Holdings remains unchanged, holding at an Equalweight rating with a $42.00 price target. Based on current metrics, the stock trades at high valuation multiples across several measures, though InvestingPro analysis suggests the company could be undervalued. Subscribers can access 18 additional ProTips and a comprehensive Pro Research Report, which provides deeper insights into the company’s financial health, growth prospects, and market position.

In other recent news, Celsius Holdings has announced its anticipated acquisition of Alani Nutrition, with the deal expected to close in April 2025. The acquisition follows the expiration of a key waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. In leadership changes, Celsius appointed Eric Hanson as President and Chief Operating Officer, effective March 24, 2025. Hanson, who brings extensive industry experience from his previous role at PepsiCo (NASDAQ:PEP), is expected to play a crucial role in the company’s growth strategy. Analyst firms Needham and Jefferies have both raised their price targets for Celsius Holdings to $40, maintaining Buy ratings on the stock. The analysts view the Alani Nu acquisition positively, expecting it to boost earnings and market share. Needham highlighted the company’s better-than-expected recent quarterly performance, leading to revised forecasts for revenue and earnings. Jefferies also noted the acquisition’s potential to significantly increase Celsius’s sales and adjusted EBITDA in 2025. These developments reflect the company’s strategic initiatives and expected financial growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.